BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36803041)

  • 1. Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.
    Yadav G; Malhotra H; Mehta P; Sachu R; Rizvi I; Bharti VR; Kumar M; Kumar N; Ali W; Verma SP; Puri B; Dandu H
    J Investig Med; 2023 Mar; 71(3):244-253. PubMed ID: 36803041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
    Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
    Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
    Alfaro-Murillo A; Lazo-Paéz G
    Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
    Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
    Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of HScore in Reactive Hemophagocytic Lymphohistiocytosis.
    Khare N; Jinkala SR; Kanungo S
    Indian J Hematol Blood Transfus; 2021 Apr; 37(2):256-263. PubMed ID: 33867732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients.
    Nyvlt P; Schuster FS; Ihlow J; Heeren P; Spies C; Hiesgen J; Schenk T; von Brünneck AC; Westermann J; Brunkhorst FM; La Rosée P; Janka G; Lachmann C; Lachmann G
    Eur J Haematol; 2024 Jun; 112(6):917-926. PubMed ID: 38368850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the HScore and the HLH-2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort.
    Bilston L; Croden J; Taparia M; Karkhaneh M; Grossman J; Sun HL
    Eur J Haematol; 2022 Aug; 109(2):129-137. PubMed ID: 35434872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Hemophagocytic Lymphohistiocytosis Criteria and HScore in Critically Ill Patients With Severe Hemophagocytic Syndrome.
    Valade S; Monseau G; Mariotte E; Darmon M
    Crit Care Med; 2021 Sep; 49(9):e874-e879. PubMed ID: 33852445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Outcome of Secondary Hemophagocytic Lymphohistiocytosis Among SIRS Patients: Results from a Prospective Cohort Study.
    Gualdoni GA; Hofmann GA; Wohlfarth P; Winkler HM; Winkler S; Haslacher H; Thalhammer R; Makristathis A; Ratzinger F; Burgmann H
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 31010216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue.
    Kan FK; Tan CC; Von Bahr Greenwood T; Khalid KE; Supramaniam P; Hed Myrberg I; Tan LH; Henter JI
    Clin Infect Dis; 2020 May; 70(11):2247-2255. PubMed ID: 31188423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An elevated HScore is associated with poor clinical outcomes in COVID-19.
    Benavente R; Peña C; Cid A; Cabello N; Bustamante P; Álvarez M; Henríquez E; Soto A; Rubilar E
    Rev Med Chil; 2023 Feb; 151(1):15-22. PubMed ID: 37906742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore.
    Núñez-Torrón C; Ferrer-Gómez A; Moreno Moreno E; Pérez-Mies B; Villarrubia J; Chamorro S; López-Jiménez J; Palacios J; Piris-Villaespesa M; García-Cosío M
    J Clin Pathol; 2022 Jun; 75(6):383-389. PubMed ID: 33722841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature.
    Kayaaslan BU; Asilturk D; Eser F; Korkmaz M; Kucuksahin O; Pamukcuoglu M; Guner R
    J Infect Dev Ctries; 2021 Nov; 15(11):1607-1614. PubMed ID: 34898486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.
    Fardet L; Galicier L; Lambotte O; Marzac C; Aumont C; Chahwan D; Coppo P; Hejblum G
    Arthritis Rheumatol; 2014 Sep; 66(9):2613-20. PubMed ID: 24782338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.
    Chu R; van Eeden C; Suresh S; Sligl WI; Osman M; Cohen Tervaert JW
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.